Gunderson Dettmer represented client Health Velocity Capital in the formation of its $300 million second fund, Health Velocity Capital II. The new fund will support early and growth-stage companies contributing to a more affordable, sustainable, and consumer-friendly healthcare system.

In the announcement of the fund, partner at Health Velocity Capital, Marty Felsenthal noted “We are extremely grateful to have the support and confidence of an outstanding group of institutional investors, strategic limited partners — and they are true partners — and senior healthcare executives who give us the opportunity to work with and for these amazing teams who are aligned with our mission of helping to build a more affordable, sustainable, consumer-friendly healthcare system. We are driven by a desire to excel for our entrepreneurs and our investors; we believe we have a highly unique model, set of relationships, and set of proof points that enable us to do this; and we never take for granted the responsibility and confidence placed in us by our investors and entrepreneurs.”

The Gunderson deal team was led by Nick Guttilla and Tyler Kirtley and included Chris Bates and Blake Rowe.

Companies:
Health Velocity Capital